WallStreetZenWallStreetZen

NYSEMKT: NNVC
Nanoviricides Inc Stock

$1.13-0.04 (-3.42%)
Updated Jun 6, 2023
NNVC Price
$1.13
Fair Value Price
N/A
Market Cap
$13.18M
52 Week Low
$1.04
52 Week High
$3.88
P/E
-1.92x
P/B
0.72x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$6.80M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.02
Operating Cash Flow
-$6M
Beta
0.02
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

NNVC Overview

NanoViricides, Inc. is a development stage company, which engages in the development of nanomedicine drugs against viruses. The company is headquartered in Shelton, Connecticut and currently employs 17 full-time employees. The firm is a development-stage company with several drugs in various stages of development. The firm focuses on its research and clinical programs on specific anti-viral therapeutics. The firm is engaged in the application of nanomedicine technologies to the issues of viral diseases. The firm's nanoviricide technology enables direct attacks at multiple points on a virus particle. In addition, the nanoviricide technology also simultaneously enables attacking the intracellular reproduction of the virus by incorporating one or more active pharmaceutical ingredients (APIs) within the core of the nanoviricide. The nanoviricide technology is engaged in both attacking extracellular virus thereby breaking the reinfection cycle, and simultaneously disrupting intracellular production of the virus, thereby enabling complete control of a virus infection.

Zen Score

Industry Average (26)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how NNVC scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

NNVC is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
NNVC is good value based on its book value relative to its share price (0.72x), compared to the US Biotechnology industry average (5.27x)
P/B vs Industry Valuation
NNVC is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more NNVC due diligence checks available for Premium users.

Be the first to know about important NNVC news, forecast changes, insider trades & much more!

Valuation

NNVC price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-1.92x
Industry
11.67x
Market
53.54x

NNVC price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.72x
Industry
5.27x
NNVC is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

NNVC's financial health

Profit margin

Revenue
$0.0
Net Income
-$1.7M
Profit Margin
0%
NNVC's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$18.6M
Liabilities
$348.7k
Debt to equity
0.02
NNVC's short-term assets ($9.93M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
NNVC's short-term assets ($9.93M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
NNVC's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
NNVC's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$1.7M
Investing
-$59.3k
Financing
$0.0
NNVC's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

NNVC vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
NNVC$13.18M-3.42%-1.92x0.72x
NRBO$13.16M-5.29%-0.23x0.64x
APGN$13.24M+0.56%-0.46x4.25x
FREQ$13.05M-1.08%-0.17x0.25x
AIMD$13.33M-3.62%-0.84x0.41x

Nanoviricides Stock FAQ

What is Nanoviricides's quote symbol?

(NYSEMKT: NNVC) Nanoviricides trades on the NYSEMKT under the ticker symbol NNVC. Nanoviricides stock quotes can also be displayed as NYSEMKT: NNVC.

If you're new to stock investing, here's how to buy Nanoviricides stock.

What is the 52 week high and low for Nanoviricides (NYSEMKT: NNVC)?

(NYSEMKT: NNVC) Nanoviricides's 52-week high was $3.88, and its 52-week low was $1.04. It is currently -70.88% from its 52-week high and 8.65% from its 52-week low.

How much is Nanoviricides stock worth today?

(NYSEMKT: NNVC) Nanoviricides currently has 11,666,000 outstanding shares. With Nanoviricides stock trading at $1.13 per share, the total value of Nanoviricides stock (market capitalization) is $13.18M.

Nanoviricides stock was originally listed at a price of $35.00 in Oct 26, 2005. If you had invested in Nanoviricides stock at $35.00, your return over the last 17 years would have been -96.77%, for an annualized return of -18.29% (not including any dividends or dividend reinvestments).

How much is Nanoviricides's stock price per share?

(NYSEMKT: NNVC) Nanoviricides stock price per share is $1.13 today (as of Jun 6, 2023).

What is Nanoviricides's Market Cap?

(NYSEMKT: NNVC) Nanoviricides's market cap is $13.18M, as of Jun 7, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Nanoviricides's market cap is calculated by multiplying NNVC's current stock price of $1.13 by NNVC's total outstanding shares of 11,666,000.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.